Randomized phase II trial of daily administrations versus alternate-day administrations of S-1 in patients with advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 13 Aug 2016 Status changed from active, no longer recruiting to completed.
- 15 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 30 Dec 2011 New trial record